Pediatric Health

oxygen delivery
Pediatric Health Respiratory

New Clinical Guideline on Home Oxygen for Children

The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb. 1 edition of the Society’s American Journal of Respiratory and Critical Care Medicine. “Home Oxygen Therapy for Children: An Official American Thoracic Society Clinical Practice Guideline”   makes specific recommendations […]

orkambi for cystic fibrosis
Pediatric Health Pharmacological Sleep Disorders

FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]

Pediatric Health Product News Respiratory

Respiratory Motion Announces FDA Clearance for Use of ExSpironTM 1Xi Minute Ventilation Monitor in Peds

The FDA has granted 510(k) clearance to the newest version of Respiratory Motion Inc’s ExSpiron Minute Ventilation (MV) monitoring system. The device will launch at the Society for Pediatric Anesthesia-American Academy of Pediatrics in Phoenix, March 23-25. Respiratory failure can occur anywhere in the hospital and early detection can often […]